Efficacy and Safety Evaluation of Taohong Siwu Decoction(桃红四物汤) for Patients with Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials

Tian-qi TAO; Hui-min MAO; Lei XIA; Xiu-hua LIU

doi:10.1007/s11655-019-3028-4

Your Location：

Home >

Browse articles >

Efficacy and Safety Evaluation of Taohong Siwu Decoction(桃红四物汤) for Patients with Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials

Evidence-Based Integrative Medicine | Updated：2021-09-01

- Efficacy and Safety Evaluation of Taohong Siwu Decoction(桃红四物汤) for Patients with Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials
- Chinese Journal of Integrative Medicine Vol. 27, Issue 8, Pages: 626-632(2021)
- Affiliations：
  
  1.Department of Pathophysiology, Chinese PLA General Hospital, Beijing(100853), China
  2.Department of Nephrology, Guang'anmen Hospital, Beijing(100053), China
- Author bio：
  
  Prof. LIU Xiu-hua, E-mail: xiuhualiu98@163.com
- Funds：
- DOI：10.1007/s11655-019-3028-4
  CLC：
- Published：01 August 2021，
  
  Published Online：02 April 2019，
  
  Accepted：30 May 2017
Scan for full text
Tian-qi TAO, Hui-min MAO, Lei XIA, et al. Efficacy and Safety Evaluation of Taohong Siwu Decoction(桃红四物汤) for Patients with Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials. [J]. Chinese Journal of Integrative Medicine 27(8):626-632(2021)
DOI：

Tian-qi TAO, Hui-min MAO, Lei XIA, et al. Efficacy and Safety Evaluation of Taohong Siwu Decoction(桃红四物汤) for Patients with Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials. [J]. Chinese Journal of Integrative Medicine 27(8):626-632(2021) DOI： 10.1007/s11655-019-3028-4.

摘要

Abstract

Objective:

To assess the efficacy and safety of Taohong Siwu Decoction (桃红四物汤

TSD)

a Chinese herbal compound prescription

in patients with angina pectoris (AP).

Methods:

Randomized clinical trials (RCTs) comparing TSD plus conventional treatment (CT) with CT plus placebo or CT only in the patients with AP were searched in PubMed

Cochrane Library

Excerpta Medica Database

Chinese National Knowledge Infrastructure

Chinese Biomedical Literature Database

Wanfang Database

Chinese Scientific Journal Database

Chinese Clinical Trial Registry and International Clinical Trial Registry from their inception to March 2017. The primary outcomes include a composite event of death

acute myocardial infarction (AMI)

and target vessel revascularization. The secondary outcomes include angina symptom

electrocardiogram (ECG) improvement and serum high-sensitivity C-reactive protein (hs-CRP)

endothelin-1 (ET-1)

triglycerides (TG)

total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels. The methodological quality of included studies and extracted available data were assessed. RevMan 5.3 software was used to conduct statistical analysis. The relative risk (RR) and standardized mean difference (SMD) with 95% confidence interval (CI) was calculated. A funnel plot was used to evaluate the publication bias.

Results:

Among 204 studies identified in the literature search

12 trials including 959 patients with AP met the inclusion criteria. No studies reported the primary outcome including death

AMI and target vessel revascularization. TSD combined with CT showed significant improvement in relieving angina symptom [RR=3.70

95% CI (2.42

5.67)] and ECG [RR=3.20

95% CI (2.20

4.65)] compared with CT alone. TSD combined with CT reduced the serum hs-CRP

TC and LDL-C levels compared with CT alone. No serious adverse events were reported in TSD combined with CT.

Conclusions:

TSD combined with CT has a potential benefit on relieving AP without significant adverse events. However

the efficacy on the cardiovascular events needs to be assessed by more rigorously-designed

largescale

and multi-center RCTs in future.

关键词

Keywords

Taohong Siwu Decoctionsystematic reviewmeta-analysisangina pectorisrandomized controlled trialChinese medicine

references

GBD 2013 Mortality and Causes of Death Collaborators.Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117-171.

Wang W, Hu SS, Kong LZ, Gao RL, Zhu ML, Wang WY, et al. Summary of report on cardiovascular diseases in China, 2012. Biomed Environ Sci 2014;27:552-558.

Task Force Members. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003.

Parikh R, Kadowitz PJ. Angina pectoris: current therapy and future treatment options. Expert Rev Cardiovasc Ther 2014;12:175-186.

White WB, Johnson MF, Anders RJ, Elliott WJ, Black HR.Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease. Am Heart J 2001;142:1010-1015.

Dixit D, Kimborowicz K. Pharmacologic management of chronic stable angina. J Am Acad Phys 2015;28.

Rui YR. Taohong Siwu Decoction combined with venomin antiembolic enzyme in treating unstable angina pectoris.Liaoning J Tradit Chin Med (Chin) 2002;29:674-675.

Liu LJ. Modified Taohong Siwu Decoction on 64 cases of stable angina pectoris. Tianjin J Tradit Chin Med (Chin)2006;23:434.

Deng RC. Clinical observation on treatment of angina pectoris with integrated Chinese and Western medicine. J Clin Exp Med (Chin) 2010;9:787-788.

Xiao ZQ. Curative effect in treating angina pectoris with integrative Chinese and Western medicine. Strait Pharm J(Chin) 2007;19:101-102.

Wang XB. Clinical observation of integrative Chinese and Western medicine in treating 46 cases with angina pectoris.Chin Pract Med (Chin) 2013;8:182.

He YY, Zhu ZX, Wang HQ. The effect observation and nursing of Taohong Siwu Decoction in treating 30 cases with unstable angina pectoris. Chin Pharm (Chin) 2011;20:76-77.

Jing XM, Wang XH. Taohong Siwu Decoction combined with sodium ozagrel injection in treating unstable angina pectoris.Hebei J Tradit Chin Med (Chin) 2009;31:1193-1203.

Chen B. The effect of Taohong Siwu Decoction on vasospastic angina with qi stagnation and blood stasis and its influence on ET-1[dissertation]. Harbin: Heilongjiang University of Chinese Medicine; 2013.

Yu SF. Clinical research on Taohong Siwu Decoction combined with conventional Western medicine for treating angina pectoris in coronary heart disease. Henan Tradit Chin Med (Chin) 2015;35:1527-1529.

Li X. Chinese and Western medicine combination therapy clinical observation of 40 cases of coronary heart disease.Chin J Ethnomed Ethnopharmacy (Chin) 2015;24:110-111.

Zheng GY, Wang JX, Li JG. The effect observation of Taohong Siwu Decoction combined with Huangqi in treating unstable angina pectoris. Chin J Tradit Med Sci Tech (Chin)2010;17:357-358.

Liu ZQ, Yin DK, Han L, Li BK, Peng DY. Protective effect of medicated serum prepared with Taohong Siwu Decoction on hydrogen peroxide-induced human umbilical vein endothelial cells. China J Chin Meter Med (Chin) 2013;38:402-406.

Bourassa MG, Alderman EL, Bertrand M, de la Fuente L, Gratsianski A, Kaltenbach M, et al. Report of the joint meeting of the International Society and Federation of Cardiology and the World Health Organization Task Force on Coronary Angioplasty. Arch Mal Coeur Vaiss 1989;82:2053-2063.

Chinese Society of Cardiology of Chinese Medical Association; Editorial Board of Chinese Journal of Cardiology.Guideline for diagnosis and treatment of patients with unstable angina and non-ST-segment elevation myocardial infarction.Chin J Cardiol (Chin) 2007;35:295-304.

Chinese Society of Cardiology of Chinese Medical Association; Editorial Board of Chinese Journal of Cardiology.Chinese guidelines for prevention of cardiovascular diseases.Chin J Cardiol (Chin) 2011;39:3-22.

Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions: Version 5.1.0. The Cochrane Collaboration 2011. Available at: www.cochrane-handbook.orgwww.cochrane-handbook.org.

Chu LX, Sun MZ, Zhang W, Luo XY, Chen L, Ma LH, et al.The effect of modified Taohong Siwu Decoction on hs-CRP of patients with coronary heart disease. Nei Mongol J Tradit Chin Med (Chin) 2014;3:36-37.

Wang JF, Zhang SZ, Zhang NY, Wu ZY, Feng JY, Ying LP, et al. Laparoscopic gastrectomy versus open gastrectomy for elderly patients with gastric cancer: a systematic review and meta-analysis. World J Surg Oncol 2016;14:90.

Yang X, Xiong X, Yang G, Wang J. Chinese patent medicine Xuefu Zhuyu Capsule for the treatment of unstable angina pectoris: A systematic review of randomized controlled trials. Complement Ther Med 2014;22:391-399.

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis

Tanreqing Injection (痰热清注射液) for Patients with Influenza: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Effect of Zhizhu Kuanzhong Capsules (枳术宽中胶囊) on Treatment of Functional Dyspepsia: A Meta-Analysis of Randomized Controlled Trials

Blood-Letting Therapy for Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effect and Safety of Herbal Medicine Foot Baths in Patients with Diabetic Peripheral Neuropathy: A Multicenter Double-Blind Randomized Controlled Trial

Related Author

No data

Related Institution

Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for Traditional Chinese Medicine Compatibility,Shaanxi University of Chinese Medicine

Nanjing Bestform Pharmaceutical Technology Co., Ltd.

Cardiovascular Department,Guang'anmen Hospital, School of Clinical Medicine, Beijing University of Chinese Medicine

School of Public Health, Shaanxi University of Chinese Medicine

International Programs Office,Shaanxi University of Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰